Efficacy of Duloxetine on cognition, depression, and pain in elderly Patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trialRASKIN, Joel; WILTSE, Curtis G; SIEGAL, Alan et al.The American journal of psychiatry. 2007, Vol 164, Num 6, issn 0002-953X, 900-902, 905-911 [10 p.]Article

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of FibromyalgiaMEASE, Philip J; RUSSELL, I. Jon; KAJDASZ, Daniel K et al.Seminars in arthritis and rheumatism. 2010, Vol 39, Num 6, pp 454-464, issn 0049-0172, 11 p.Article

Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failureBRYNNE, Lena; MCNAY, John L; SCHAEFER, Hans G et al.British journal of clinical pharmacology. 2001, Vol 51, Num 1, pp 35-43, issn 0306-5251Article

Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive DisorderRASKIN, Joel; WILTSE, Curtis G; DINKEL, James J et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 1, pp 32-38, issn 0271-0749, 7 p.Article

Duloxetine in the prevention of relapse of major depressive disorder : Double-blind placebo-controlled studyPERAHIA, David G; GILABERTE, Inmaculada; FUJUN WANG et al.British journal of psychiatry (Print). 2006, Vol 188, Num AVR, pp 346-353, issn 0007-1250, 8 p.Article